Polycystic ovarian syndrome (July 7, 2025) Androgen excess: a hallmark of polycystic ovary syndrome (December 13, 2023) Increased Prevalence of Elevated DHEAS in PCOS Women with Non-Classic (B or C) Phenotypes: A Retrospective Analysis in Patients Aged 20 to 29 Year (Oct 17, 2022) OZEMPIC (semaglutide) injection, for subcutaneous use
They do not change food preferences, repair sleep, or build muscle
The FDA has removed the designation of shortages for Ozempic, but there is a 60-day grace period that compounding pharmacies can continue making it until April 22, 2025
After reconstitution, store at 2-8C and use within 21 days
Substances sold online as retatrutide, including those labelled for research use only, are not FDA-approved Lilly medicines